CAR-T Cell Therapy for Solid Tumors

Background: Chimeric antigen receptor (CAR)-modified T cells have shown remarkable results for the treatment of selected hematological malignancies, but recapitulating these results in solid cancers has been a major challenge. In this review, we discuss lessons learned from recent clinica...

Full description

Saved in:
Bibliographic Details
Main Authors: Liz T. Tony, Andrea Stabile, Marc P. Schauer, Michael Hudecek, Justus Weber
Format: Article
Language:English
Published: Karger Publishers 2025-01-01
Series:Transfusion Medicine and Hemotherapy
Online Access:https://karger.com/article/doi/10.1159/000542438
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items